Stephen LaMond - Sep 15, 2023 Form 4/A - Amendment Insider Report for Peak Bio, Inc. (PKBO)

Role: Interim Chief Executive Officer, Director
Signature: /s/ Dr. Stephen LaMond
Stock symbol: PKBO
Transactions as of: Sep 15, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 9/28/2023, 05:05 PM
Date Of Original Report: Sep 19, 2023
Previous filing: Nov 3, 2022
Next filing: Sep 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PKBO	Common Stock	Purchase		+11.8K			11.8K	Sep 15, 2023	Direct	F1
transaction	PKBO	Common Stock	Purchase		+2.5K	+21.28%		14.3K	Sep 18, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Dr. LaMond previously reported purchases of 26,000 shares of the Company's Common Stock on September 15, 2023 in error. Instead, on September 15, 2023, Dr. Stephen LaMond purchased a total of 11,750 shares of the Company's Common Stock at prices ranging from $0.27 per share to $0.43 per share.
F2	On September 18, 2023, Dr. Stephen LaMond purchased a total of 2,500 shares of the Company's Common Stock at prices ranging from $0.23 per share to $0.29 per share.

Remarks:

Interim Chief Executive Officer